Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model

Cell Mol Gastroenterol Hepatol. 2019;8(2):193-195. doi: 10.1016/j.jcmgh.2019.05.001. Epub 2019 May 9.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colitis / drug therapy*
  • Disease Models, Animal*
  • Interleukin-2 / therapeutic use*
  • Mice

Substances

  • Interleukin-2